Yahoo! Finance Search - Finance Home - Yahoo! - Help

Thursday, November 26 2015 12:08am ET - U.S. Markets open in 9 hours and 22 minutes.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Diagnostic Substances News
Latest News
Monday, Nov 23, 2015
·Oxford Immunotec Ranked Among Deloitte’s 2015 Technology Fast 500™
GlobeNewswire - Mon Nov 23
·AMAG Pharmaceuticals Responds to Recent Complete Response Letter From the FDA for the Single-Dose, Preservative-Free Vial of Makena(R)
GlobeNewswire - Mon Nov 23
Friday, Nov 20, 2015
·4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming
- Fri Nov 20
·SurModics Acquires Creagh Medical, a Developer and Manufacturer of Balloon Catheters
Business Wire - Fri Nov 20
Thursday, Nov 19, 2015
·INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud by AMAG Pharmaceuticals, Inc. and Certain Officers and Directors
Business Wire - Thu Nov 19
·SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG
- Thu Nov 19
Wednesday, Nov 18, 2015
·FDA rejects AMAG Pharma's single-dose hormone injection
Reuters - Wed Nov 18
·AMAG Pharmaceuticals Receives Complete Response Letter From FDA for Single-Dose, Preservative-Free Vial of Makena(R) (hydroxyprogesterone caproate injection)
GlobeNewswire - Wed Nov 18
·Meridian Receives FDA Clearance for New Molecular Whooping Cough Test Claims
Business Wire - Wed Nov 18
Tuesday, Nov 17, 2015
·Charlie Slacik Joins Quidel's Board of Directors
Marketwire - Tue Nov 17
·Vermillion to Present Corporate Overview at the Canaccord Genuity Medical Technology & Diagnostics Forum
PR Newswire - Tue Nov 17
Friday, Nov 13, 2015
·Cincinnati firm ‘takes a nibble’ of possible acquisition
at - Fri Nov 13
·Oxford Immunotec to Present at the 27th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Fri Nov 13
·CEMI: Fever Portfolio Charging Out of the Gate
- Fri Nov 13
Thursday, Nov 12, 2015
·Atossa Genetics Announces Third Quarter 2015 Financial Results and Provides Company Update
Marketwire - Thu Nov 12
·MYnd Analytics to be Featured on Varney & Co.
GlobeNewswire - Thu Nov 12
·Meridian Bioscience Announces Investment in Oasis Diagnostics®
Business Wire - Thu Nov 12
·Vermillion reports 3Q loss
AP - Thu Nov 12
·Oculus Innovative Sciences Beats Analyst Expectations, Even More than at First Blush
- Thu Nov 12
·Chembio Diagnostics Reports Third Quarter Financial Results
GlobeNewswire - Thu Nov 12
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Diagnostic Substances Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?